-
The blitz expanded Russia's almost daily bombardment of Ukrainian cities as Moscow apparently looked to exploit Kyiv's critical shortage of Western-supplied anti-ballistic missile defenses.
-
Odysseus did not face the parasite Cyclospora in his 10-year journey home. But the word "parasite" originated as a popular character trope in Greek literature.
-
Robeson County, N.C., where most of the Lumbee Tribe's citizens live, ranks as one of the worst counties in the U.S. for health. The tribe can access the Indian Health Service now, but it's not likely to be sufficient to improve the health of the community.
-
Should students be allowed to use AI on assignments? What about on tests? Who should teach AI literacy? About 100 teenagers got together to try to decide.
-
Housing has long been the largest source of wealth for middle income families. But many renters cannot afford to buy as housing prices soar, which could fuel a generational divide.
-
There's a reason why double- or triple-screening your devices makes you feel tired, says NPR's Manoush Zomorodi. She explains the science of information overload and how to reclaim calm and focus.
The Trump administration's upending of years of vaccine advice puts many pediatricians in a quandary. Some are steering patients away from the CDC to other authoritative websites, including their own.
-
The Senate Judiciary Committee had been expected to vote Thursday on whether to advance Todd Blanche's nomination. But resistance from two Republican senators threw his confirmation into doubt.
-
A man was convicted of federal terrorism charges in the 2022 stabbing of Salman Rushdie, the author who has faced a decades-old death threat over his novel "The Satanic Verses."
-
Time was running out to find survivors, as rescuers continued to work in the Kumamoto area on Japan 's southern main island of Kyushu, where the magnitude 7.1 earthquake hit Tuesday.
-
The release of Dr. Anthony Fauci's pandemic diaries has rekindled the debate over the origins of SARS-CoV-2. Here's how scientists have weighed in.
-
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.